Ultane Liquid
NDC Package 0074-4456-04
Package Information
Ultane (sevoflurane) liquids is uLTANE is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.ULTANE should be administered only by persons trained in the administration of general anesthesia. This formulation utilizes a liquid delivery system. Marketed by Abbvie Inc., this product is identified by NDC 0074-4456 and is authorized under FDA application NDA020478.
Identification & Billing
- RxCUI: 200243 - sevoflurane 100 % Inhalation Solution
- RxCUI: 200243 - sevoflurane 1000 MG/ML Inhalation Solution
- RxCUI: 541963 - ULTANE 100 % Inhalation Solution
- RxCUI: 541963 - sevoflurane 1000 MG/ML Inhalation Solution [Ultane]
- RxCUI: 541963 - Ultane 100 % Inhalation Solution
Clinical Specifications
- Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
- Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Regulatory & Marketing
Hierarchy Structure
- 0074 - Abbvie Inc.
- 0074-4456 - Ultane
- 0074-4456-04 - 250 mL in 1 BOTTLE, PLASTIC
- 0074-4456 - Ultane
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0074-4456). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0074-4456-04 identifies a specific commercial package of 250 ml in 1 bottle, plastic of Ultane, a human prescription drug labeled by Abbvie Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 250 billable units per package. This liquid is formulated for respiratory (inhalation) use and contains sevoflurane as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Abbvie Inc. on June 07, 1995. The current certification is valid through December 31, 2026.
How is this Abbvie Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00074445604. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 250 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.